Diagnosis and Pharmacotherapy of Alcohol Use Disorder | Zendy

Henry R. Kranzler | Zendy; Michael Soyka | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diagnosis and Pharmacotherapy of Alcohol Use Disorder

Author(s) -

Henry R. Kranzler,

Michael Soyka

Publication year - 2018

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2018.11406

Subject(s) - medicine , acamprosate , alcohol use disorder , naltrexone , disulfiram , topiramate , psychiatry , alcohol dependence , binge drinking , pharmacotherapy , nalmefene , alcohol , poison control , emergency medicine , injury prevention , pharmacology , opioid , biochemistry , chemistry , receptor , epilepsy

Alcohol consumption is associated with 88 000 US deaths annually. Although routine screening for heavy alcohol use can identify patients with alcohol use disorder (AUD) and has been recommended, only 1 in 6 US adults report ever having been asked by a health professional about their drinking behavior. Alcohol use disorder, a problematic pattern of alcohol use accompanied by clinically significant impairment or distress, is present in up to 14% of US adults during a 1-year period, although only about 8% of affected individuals are treated in an alcohol treatment facility.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research